Company Filing History:
Years Active: 2008-2023
Title: Keiichi Yamaguchi: Innovator in Blood Coagulation Analysis
Introduction
Keiichi Yamaguchi is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of blood coagulation analysis, holding a total of 3 patents. His work focuses on improving methods and apparatuses for analyzing blood coagulation, which is crucial for various medical applications.
Latest Patents
Yamaguchi's latest patents include a blood coagulation analyzing method, apparatus, and a non-transitory computer-readable storage medium for determining the occurrence of an early reaction error. This method involves calculating a coagulation time based on data representing a coagulation curve of a blood specimen. It also includes calculating an index value related to derivatives concerning the coagulation curve and determining whether an early reaction error has occurred based on a comparison with a predetermined threshold. Another significant patent is for a sample analyzer and sample analysis method. This analyzer features an input to select a sample type, a measurement part to obtain optical information, and a processing part that calculates platelet aggregation information. The processing part also determines if the actual measured sample type differs from the inputted sample type and actuates an alarm accordingly.
Career Highlights
Keiichi Yamaguchi is currently employed at Sysmex Corporation, a company known for its advanced medical diagnostic equipment. His work at Sysmex has allowed him to develop innovative solutions that enhance the accuracy and efficiency of blood analysis.
Collaborations
Yamaguchi collaborates with talented individuals such as Hiroshi Kurono and Hideo Kusuzawa. Their combined expertise contributes to the advancement of technologies in the medical field.
Conclusion
Keiichi Yamaguchi's contributions to blood coagulation analysis through his patents and work at Sysmex Corporation highlight his role as an influential inventor in the medical technology sector. His innovations continue to impact the way blood coagulation is analyzed and understood.